Reverba, renowned for its innovative patient engagement solutions for biopharmaceutical companies, today announced the acquisition of Six Degrees Worldwide Inc., a leader in medical communications within the same industry. The acquisition is poised to help Reverba and its clients continue to bridge the gap between science and real-life patient experiences.
Reverba’s acquisition will enable the integration of Six Degrees’ comprehensive suite of medical communication services into its innovative patient engagement approach and platforms. This synergy will simplify the delivery of complex scientific information into formats that are easily comprehensible for patients, caregivers, and healthcare professionals.
“Our goal has always been to empower patients with engaging, understandable, and actionable healthcare information and connections,” said Cheryl Lubbert, Reverba Co-Founder and CEO. “By joining forces with Six Degrees, we are set to revolutionize how scientific information is communicated to and understood by patients globally. This is a leap towards making science accessible and meaningful to the lives it aims to improve.”
Robin Kerbel, Co-Founder of Six Degrees, expressed enthusiasm about the acquisition, “This partnership with Reverba represents a pivotal step forward in our growth. Together, we have the potential to set new standards in medical communications, making it more meaningful, patient-friendly, and impactful. We are excited to be a part of this journey that places patients at the heart of healthcare innovation.”
The acquisition by Reverba and 424 Capital, a growth capital partner, is the first in a series of planned strategic acquisitions intended to strengthen Reverba’s commitment to science, patient advocacy, and transformative healthcare. Bourne Partners, a healthcare focused investment bank, advised 424 Capital on the initial acquisition.
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!
